NEW YORK (GenomeWeb) – Illumina today announced an alliance with Germany's Merck KGaA and Australian fertility firm Genea to improve fertility-related technologies and laboratory processes.

The alliance will work to standardize assisted reproductive treatment (ART) laboratory processes. "This will ensure a consistently high level of performance between different centers and countries," Merck KGaA Head of Global Strategy and Franchises Meeta Gulyani said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, NJ.com writes.

The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.

Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.

In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.